#locus	locus_size_mb	gene	OMIM_number	OMIM_details
chr15:50689270-69990570	19.301	AAGAB	614888	(provisional) Keratoderma,palmoplantar,punctate type IA,148600
chr15:50689270-69990570	19.301	ADAM10	602192	(provisional) Reticulate acropigmentation of Kitamura,615537|Alzheimer disease 18,susceptibility to,615590
chr15:50689270-69990570	19.301	ALDH1A2		
chr15:50689270-69990570	19.301	ANKDD1A		
chr15:50689270-69990570	19.301	ANP32A		
chr15:50689270-69990570	19.301	ANXA2		
chr15:50689270-69990570	19.301	AP4E1	607244	(provisional) Spastic paraplegia 51,autosomal recessive,613744|Stuttering,familial persistent,1,184450
chr15:50689270-69990570	19.301	APH1B		
chr15:50689270-69990570	19.301	AQP9		
chr15:50689270-69990570	19.301	ARPP19		
chr15:50689270-69990570	19.301	BCL2L10		
chr15:50689270-69990570	19.301	BNIP2		
chr15:50689270-69990570	19.301	C15ORF61		
chr15:50689270-69990570	19.301	C15ORF65		
chr15:50689270-69990570	19.301	C2CD4A		
chr15:50689270-69990570	19.301	C2CD4B		
chr15:50689270-69990570	19.301	CA12	603263	(provisional) Hyperchlorhidrosis,isolated,143860
chr15:50689270-69990570	19.301	CALML4		
chr15:50689270-69990570	19.301	CCNB2		
chr15:50689270-69990570	19.301	CCPG1		
chr15:50689270-69990570	19.301	CGNL1		
chr15:50689270-69990570	19.301	CILP	603489	(provisional) Lumbar disc disease,susceptibility to,603932
chr15:50689270-69990570	19.301	CLN6	606725	(confirmed) Ceroid lipofuscinosis,neuronal,6,601780|Ceroid lipofuscinosis,neuronal,Kufs type,adult onset,204300
chr15:50689270-69990570	19.301	CLPX		
chr15:50689270-69990570	19.301	CORO2B		
chr15:50689270-69990570	19.301	CSNK1G1		
chr15:50689270-69990570	19.301	CYP19A1	107910	(confirmed) Aromatase deficiency,613546|Aromatase excess syndrome,139300
chr15:50689270-69990570	19.301	DAPK2		
chr15:50689270-69990570	19.301	DENND4A		
chr15:50689270-69990570	19.301	DIS3L		
chr15:50689270-69990570	19.301	DMXL2	612186	(provisional) Polyendocrine-polyneuropathy syndrome,616113
chr15:50689270-69990570	19.301	DNAAF4		
chr15:50689270-69990570	19.301	DPP8		
chr15:50689270-69990570	19.301	DYX1C1	608706	(confirmed) Dyslexia,susceptibility to,1,127700|Ciliary dyskinesia,primary,25,615482
chr15:50689270-69990570	19.301	FAM214A		
chr15:50689270-69990570	19.301	FAM81A		
chr15:50689270-69990570	19.301	FAM96A		
chr15:50689270-69990570	19.301	FBXL22		
chr15:50689270-69990570	19.301	FEM1B		
chr15:50689270-69990570	19.301	FOXB1		
chr15:50689270-69990570	19.301	GCNT3		
chr15:50689270-69990570	19.301	GCOM1		
chr15:50689270-69990570	19.301	GLCE		
chr15:50689270-69990570	19.301	GLDN	608603	(provisional) Lethal congenital contracture syndrome 11,617194
chr15:50689270-69990570	19.301	GNB5	604447	(provisional) Intellectual developmental disorder with cardiac arrhythmia,617173|Language delay and ADHD/cognitive impairment with or without cardiac arrhythmia,617182
chr15:50689270-69990570	19.301	GTF2A2		
chr15:50689270-69990570	19.301	HACD3		
chr15:50689270-69990570	19.301	HERC1	605109	(provisional) Macrocephaly,dysmorphic facies,and psychomotor retardation,617011
chr15:50689270-69990570	19.301	ICE2		
chr15:50689270-69990570	19.301	IGDCC3		
chr15:50689270-69990570	19.301	IGDCC4		
chr15:50689270-69990570	19.301	INTS14		
chr15:50689270-69990570	19.301	IQCH		
chr15:50689270-69990570	19.301	ITGA11		
chr15:50689270-69990570	19.301	KBTBD13	613727	(provisional) Nemaline myopathy 6,autosomal dominant,609273
chr15:50689270-69990570	19.301	KIF23		
chr15:50689270-69990570	19.301	LACTB		
chr15:50689270-69990570	19.301	LCTL		
chr15:50689270-69990570	19.301	LDHAL6B		
chr15:50689270-69990570	19.301	LEO1		
chr15:50689270-69990570	19.301	LIPC	151670	(confirmed) High density lipoprotein cholesterol level QTL 12,612797|Diabetes mellitus,noninsulin-dependent,125853|Hepatic lipase deficiency,614025
chr15:50689270-69990570	19.301	LYSMD2		
chr15:50689270-69990570	19.301	MAP2K1	176872	(confirmed) Cardiofaciocutaneous syndrome 3,615279
chr15:50689270-69990570	19.301	MAP2K5		
chr15:50689270-69990570	19.301	MAPK6		
chr15:50689270-69990570	19.301	MEGF11		
chr15:50689270-69990570	19.301	MINDY2		
chr15:50689270-69990570	19.301	MNS1		
chr15:50689270-69990570	19.301	MTFMT	611766	(provisional) Combined oxidative phosphorylation deficiency 15,614947
chr15:50689270-69990570	19.301	MYO1E	601479	(provisional) Glomerulosclerosis,focal segmental,6,614131
chr15:50689270-69990570	19.301	MYO5A	160777	(confirmed) Griscelli syndrome,type 1,214450
chr15:50689270-69990570	19.301	MYO5C		
chr15:50689270-69990570	19.301	MYZAP		
chr15:50689270-69990570	19.301	NEDD4		
chr15:50689270-69990570	19.301	NOX5		
chr15:50689270-69990570	19.301	OAZ2		
chr15:50689270-69990570	19.301	ONECUT1		
chr15:50689270-69990570	19.301	PAQR5		
chr15:50689270-69990570	19.301	PARP16		
chr15:50689270-69990570	19.301	PCLAF		
chr15:50689270-69990570	19.301	PDCD7		
chr15:50689270-69990570	19.301	PIAS1		
chr15:50689270-69990570	19.301	PIF1		
chr15:50689270-69990570	19.301	PIGB		
chr15:50689270-69990570	19.301	PLEKHO2		
chr15:50689270-69990570	19.301	POLR2M		
chr15:50689270-69990570	19.301	PPIB	123841	(provisional) Osteogenesis imperfecta,type IX,259440
chr15:50689270-69990570	19.301	PRTG		
chr15:50689270-69990570	19.301	PYGO1		
chr15:50689270-69990570	19.301	RAB11A		
chr15:50689270-69990570	19.301	RAB27A	603868	(provisional) Griscelli syndrome,type 2,607624
chr15:50689270-69990570	19.301	RAB8B		
chr15:50689270-69990570	19.301	RASL12		
chr15:50689270-69990570	19.301	RBPMS2		
chr15:50689270-69990570	19.301	RFX7		
chr15:50689270-69990570	19.301	RNF111		
chr15:50689270-69990570	19.301	RORA		
chr15:50689270-69990570	19.301	RPL4		
chr15:50689270-69990570	19.301	RPLP1		
chr15:50689270-69990570	19.301	RPS27L		
chr15:50689270-69990570	19.301	RSL24D1		
chr15:50689270-69990570	19.301	SCG3		
chr15:50689270-69990570	19.301	SKOR1		
chr15:50689270-69990570	19.301	SLC24A1	603617	(provisional) Night blindness,congenital stationary (complete),1D,autosomal recessive,613830
chr15:50689270-69990570	19.301	SLC51B		
chr15:50689270-69990570	19.301	SLTM		
chr15:50689270-69990570	19.301	SMAD3	603109	(provisional) Loeys-Dietz syndrome 3,613795
chr15:50689270-69990570	19.301	SMAD6	602931	(provisional) Aortic valve disease 2,614823|Craniosynostosis 7,susceptibility to,617439
chr15:50689270-69990570	19.301	SNAPC5		
chr15:50689270-69990570	19.301	SNX1		
chr15:50689270-69990570	19.301	SNX22		
chr15:50689270-69990570	19.301	SPESP1		
chr15:50689270-69990570	19.301	SPG21	608181	(confirmed) Mast syndrome,248900
chr15:50689270-69990570	19.301	SPPL2A		
chr15:50689270-69990570	19.301	TCF12	600480	(confirmed) Craniosynostosis 3,615314
chr15:50689270-69990570	19.301	TEX9		
chr15:50689270-69990570	19.301	TIPIN		
chr15:50689270-69990570	19.301	TLN2		
chr15:50689270-69990570	19.301	TMOD2		
chr15:50689270-69990570	19.301	TMOD3		
chr15:50689270-69990570	19.301	TNFAIP8L3		
chr15:50689270-69990570	19.301	TPM1	191010	(confirmed) Cardiomyopathy,hypertrophic,3,115196|Cardiomyopathy,dilated,1Y,611878|Left ventricular noncompaction 9,611878
chr15:50689270-69990570	19.301	TRIP4	604501	(provisional) Spinal muscular atrophy with congenital bone fractures 1,616866|Muscular dystrophy,congenital,Davignon-Chauveau type,617066
chr15:50689270-69990570	19.301	TRPM7	605692	(provisional) Amyotrophic lateral sclerosis-parkinsonism/dementia complex,susceptibility to,105500
chr15:50689270-69990570	19.301	UBAP1L		
chr15:50689270-69990570	19.301	UNC13C		
chr15:50689270-69990570	19.301	USP3		
chr15:50689270-69990570	19.301	USP50		
chr15:50689270-69990570	19.301	USP8		
chr15:50689270-69990570	19.301	VPS13C	608879	(provisional) Parkinson disease 23,autosomal recessive,early onset,616840
chr15:50689270-69990570	19.301	WDR72	613214	(provisional) Amelogenesis imperfecta,type IIA3,613211
chr15:50689270-69990570	19.301	ZNF280D		
chr15:50689270-69990570	19.301	ZNF609		
chr15:50689270-69990570	19.301	ZWILCH		
chr1:554484-19673855	19.119	AADACL3		
chr1:554484-19673855	19.119	AADACL4		
chr1:554484-19673855	19.119	ACAP3		
chr1:554484-19673855	19.119	ACOT7		
chr1:554484-19673855	19.119	ACTL8		
chr1:554484-19673855	19.119	ACTRT2		
chr1:554484-19673855	19.119	AGMAT		
chr1:554484-19673855	19.119	AGRN	103320	(provisional) Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120
chr1:554484-19673855	19.119	AGTRAP		
chr1:554484-19673855	19.119	AJAP1		
chr1:554484-19673855	19.119	AKR7A2		
chr1:554484-19673855	19.119	AKR7A3		
chr1:554484-19673855	19.119	AKR7L		
chr1:554484-19673855	19.119	ALDH4A1	606811	(provisional) Hyperprolinemia,type II,239510
chr1:554484-19673855	19.119	ANGPTL7		
chr1:554484-19673855	19.119	ANKRD65		
chr1:554484-19673855	19.119	ARHGEF10L		
chr1:554484-19673855	19.119	ARHGEF16		
chr1:554484-19673855	19.119	ARHGEF19		
chr1:554484-19673855	19.119	ATAD3A	612316	(provisional) Harel-Yoon syndrome,617183
chr1:554484-19673855	19.119	ATAD3B		
chr1:554484-19673855	19.119	ATAD3C		
chr1:554484-19673855	19.119	ATP13A2	610513	(confirmed) Kufor-Rakeb syndrome,606693|Spastic paraplegia 78,autosomal recessive,617225
chr1:554484-19673855	19.119	AURKAIP1		
chr1:554484-19673855	19.119	B3GALT6	615291	(provisional) Spondyloepimetaphyseal dysplasia with joint laxity,type 1,with or without fractures,271640|Ehlers-Danlos syndrome,progeroid type,2,615349
chr1:554484-19673855	19.119	C1ORF127		
chr1:554484-19673855	19.119	C1ORF134		
chr1:554484-19673855	19.119	C1ORF158		
chr1:554484-19673855	19.119	C1ORF159		
chr1:554484-19673855	19.119	C1ORF167		
chr1:554484-19673855	19.119	C1ORF174		
chr1:554484-19673855	19.119	C1ORF195		
chr1:554484-19673855	19.119	C1ORF64		
chr1:554484-19673855	19.119	C1QTNF12		
chr1:554484-19673855	19.119	CA6		
chr1:554484-19673855	19.119	CALML6		
chr1:554484-19673855	19.119	CAMTA1	611501	(provisional) Cerebellar ataxia,nonprogressive,with mental retardation,614756
chr1:554484-19673855	19.119	CAPZB		
chr1:554484-19673855	19.119	CASP9		
chr1:554484-19673855	19.119	CASZ1		
chr1:554484-19673855	19.119	CCDC27		
chr1:554484-19673855	19.119	CCNL2		
chr1:554484-19673855	19.119	CDK11A		
chr1:554484-19673855	19.119	CDK11B		
chr1:554484-19673855	19.119	CELA2A		
chr1:554484-19673855	19.119	CELA2B		
chr1:554484-19673855	19.119	CENPS		
chr1:554484-19673855	19.119	CENPS-CORT		
chr1:554484-19673855	19.119	CEP104	616690	(confirmed) Joubert syndrome 25,616781
chr1:554484-19673855	19.119	CFAP74		
chr1:554484-19673855	19.119	CHD5		
chr1:554484-19673855	19.119	CLCN6		
chr1:554484-19673855	19.119	CLCNKA	602024	(confirmed) Bartter syndrome,type 4b,digenic,613090
chr1:554484-19673855	19.119	CLCNKB	602023	(confirmed) Bartter syndrome,type 3,607364|Bartter syndrome,type 4b,digenic,613090
chr1:554484-19673855	19.119	CLSTN1		
chr1:554484-19673855	19.119	CORT		
chr1:554484-19673855	19.119	CPTP		
chr1:554484-19673855	19.119	CROCC		
chr1:554484-19673855	19.119	CTNNBIP1		
chr1:554484-19673855	19.119	CTRC	601405	(provisional) Pancreatitis,chronic,susceptibility to,167800
chr1:554484-19673855	19.119	DDI2		
chr1:554484-19673855	19.119	DFFA		
chr1:554484-19673855	19.119	DFFB		
chr1:554484-19673855	19.119	DHRS3		
chr1:554484-19673855	19.119	DISP3		
chr1:554484-19673855	19.119	DNAJC11		
chr1:554484-19673855	19.119	DNAJC16		
chr1:554484-19673855	19.119	DRAXIN		
chr1:554484-19673855	19.119	DVL1	601365	(confirmed) Robinow syndrome,autosomal dominant 2,616331
chr1:554484-19673855	19.119	EFHD2		
chr1:554484-19673855	19.119	EMC1	616846	(provisional) Cerebellar atrophy,visual impairment,and psychomotor retardation,616875
chr1:554484-19673855	19.119	ENO1	172430	(confirmed) Enolase deficiency
chr1:554484-19673855	19.119	EPHA2	176946	(confirmed) Cataract 6,multiple types,116600
chr1:554484-19673855	19.119	ERRFI1		
chr1:554484-19673855	19.119	ESPN	606351	(provisional) Deafness,autosomal recessive 36,609006|Deafness,neurosensory,without vestibular involvement,autosomal dominant
chr1:554484-19673855	19.119	EXOSC10		
chr1:554484-19673855	19.119	FAAP20		
chr1:554484-19673855	19.119	FAM131C		
chr1:554484-19673855	19.119	FAM213B		
chr1:554484-19673855	19.119	FAM231A		
chr1:554484-19673855	19.119	FAM231B		
chr1:554484-19673855	19.119	FAM231C		
chr1:554484-19673855	19.119	FBLIM1		
chr1:554484-19673855	19.119	FBXO2		
chr1:554484-19673855	19.119	FBXO42		
chr1:554484-19673855	19.119	FBXO44		
chr1:554484-19673855	19.119	FBXO6		
chr1:554484-19673855	19.119	FHAD1		
chr1:554484-19673855	19.119	FNDC10		
chr1:554484-19673855	19.119	GABRD	137163	(confirmed) Epilepsy,generalized,with febrile seizures plus,type 5,susceptibility to,613060|Epilepsy,idiopathic generalized,10,613060|Epilepsy,juvenile myoclonic,susceptibility to,613060
chr1:554484-19673855	19.119	GNB1	139380	(confirmed) Mental retardation,autosomal dominant 42,616973|Leukemia,acute lymphoblastic,somatic,613065
chr1:554484-19673855	19.119	GPR153		
chr1:554484-19673855	19.119	GPR157		
chr1:554484-19673855	19.119	H6PD	138090	(confirmed) Cortisone reductase deficiency 1,604931
chr1:554484-19673855	19.119	HES2		
chr1:554484-19673855	19.119	HES3		
chr1:554484-19673855	19.119	HES4		
chr1:554484-19673855	19.119	HES5		
chr1:554484-19673855	19.119	HNRNPCL1		
chr1:554484-19673855	19.119	HSPB7		
chr1:554484-19673855	19.119	ICMT		
chr1:554484-19673855	19.119	IFFO2		
chr1:554484-19673855	19.119	IGSF21		
chr1:554484-19673855	19.119	INTS11		
chr1:554484-19673855	19.119	ISG15	147571	(provisional) Immunodeficiency 38,616126
chr1:554484-19673855	19.119	KAZN		
chr1:554484-19673855	19.119	KCNAB2		
chr1:554484-19673855	19.119	KIAA2013		
chr1:554484-19673855	19.119	KIF1B	605995	(confirmed) Charcot-Marie-Tooth disease,type 2A1,118210|Pheochromocytoma,171300|Neuroblastoma,susceptibility to,1,256700
chr1:554484-19673855	19.119	KLHDC7A		
chr1:554484-19673855	19.119	KLHL17		
chr1:554484-19673855	19.119	KLHL21		
chr1:554484-19673855	19.119	LRRC38		
chr1:554484-19673855	19.119	LRRC47		
chr1:554484-19673855	19.119	LZIC		
chr1:554484-19673855	19.119	MAD2L2	604094	(provisional) Fanconi anemia,complementation group V,617243
chr1:554484-19673855	19.119	MASP2	605102	(provisional) MASP2 deficiency,613791
chr1:554484-19673855	19.119	MEGF6		
chr1:554484-19673855	19.119	MFAP2		
chr1:554484-19673855	19.119	MFN2	608507	(confirmed) Charcot-Marie-Tooth disease,axonal,type 2A2A,609260|Hereditary motor and sensory neuropathy VIA,601152|Charcot-Marie-Tooth disease,axonal,type 2A2B,617087
chr1:554484-19673855	19.119	MIB2		
chr1:554484-19673855	19.119	MIIP		
chr1:554484-19673855	19.119	MMEL1		
chr1:554484-19673855	19.119	MMP23B		
chr1:554484-19673855	19.119	MORN1		
chr1:554484-19673855	19.119	MRPL20		
chr1:554484-19673855	19.119	MRTO4		
chr1:554484-19673855	19.119	MTHFR	607093	(provisional) Homocystinuria due to MTHFR deficiency,236250|Schizophrenia,susceptibility to,181500|Vascular disease,susceptibility to|Neural tube defects,susceptibility to,601634|Thromboembolism,susceptibility to,188050
chr1:554484-19673855	19.119	MTOR	601231	(provisional) Smith-Kingsmore syndrome,616638|Focal cortical dysplasia,type II,somatic,607341
chr1:554484-19673855	19.119	MXRA8		
chr1:554484-19673855	19.119	NADK		
chr1:554484-19673855	19.119	NBPF1		
chr1:554484-19673855	19.119	NECAP2		
chr1:554484-19673855	19.119	NMNAT1	608700	(confirmed) Leber congenital amaurosis 9,608553
chr1:554484-19673855	19.119	NOC2L		
chr1:554484-19673855	19.119	NOL9		
chr1:554484-19673855	19.119	NPHP4	607215	(provisional) Nephronophthisis 4,606966|Senior-Loken syndrome 4,606996
chr1:554484-19673855	19.119	NPPA	108780	(confirmed) Atrial fibrillation,familial,6,612201|Atrial standstill 2,615745
chr1:554484-19673855	19.119	NPPB		
chr1:554484-19673855	19.119	OR4F16		
chr1:554484-19673855	19.119	PADI1		
chr1:554484-19673855	19.119	PADI2		
chr1:554484-19673855	19.119	PADI3	606755	(provisional) Uncombable hair syndrome,191480
chr1:554484-19673855	19.119	PADI4	605347	(confirmed) Rheumatoid arthritis,susceptibility to,180300
chr1:554484-19673855	19.119	PADI6	610363	(confirmed) Preimplantation embryonic lethality 2,617234
chr1:554484-19673855	19.119	PANK4		
chr1:554484-19673855	19.119	PARK7	602533	(provisional) Parkinson disease 7,autosomal recessive early-onset,606324
chr1:554484-19673855	19.119	PAX7	167410	(confirmed) Rhabdomyosarcoma 2,alveolar,268220
chr1:554484-19673855	19.119	PDPN		
chr1:554484-19673855	19.119	PER3	603427	(provisional) Advanced sleep phase syndrome,familial,3,616882
chr1:554484-19673855	19.119	PERM1		
chr1:554484-19673855	19.119	PEX10	602859	(confirmed) Peroxisome biogenesis disorder 6A (Zellweger),614870|Peroxisome biogenesis disorder 6B,614871
chr1:554484-19673855	19.119	PEX14	601791	(provisional) Peroxisome biogenesis disorder 13A (Zellweger),614887
chr1:554484-19673855	19.119	PGD		
chr1:554484-19673855	19.119	PHF13		
chr1:554484-19673855	19.119	PIK3CD	602839	(provisional) Immunodeficiency 14,615513
chr1:554484-19673855	19.119	PIK3CD-AS1		
chr1:554484-19673855	19.119	PLCH2		
chr1:554484-19673855	19.119	PLEKHG5	611101	(confirmed) Spinal muscular atrophy,distal,autosomal recessive,4,611067|Charcot-Marie-Tooth disease,recessive intermediate C,615376
chr1:554484-19673855	19.119	PLEKHM2		
chr1:554484-19673855	19.119	PLEKHN1		
chr1:554484-19673855	19.119	PLOD1	153454	(provisional) Ehlers-Danlos syndrome,type VI,225400
chr1:554484-19673855	19.119	PQLC2		
chr1:554484-19673855	19.119	PRAMEF1		
chr1:554484-19673855	19.119	PRAMEF10		
chr1:554484-19673855	19.119	PRAMEF11		
chr1:554484-19673855	19.119	PRAMEF12		
chr1:554484-19673855	19.119	PRAMEF13		
chr1:554484-19673855	19.119	PRAMEF14		
chr1:554484-19673855	19.119	PRAMEF15		
chr1:554484-19673855	19.119	PRAMEF17		
chr1:554484-19673855	19.119	PRAMEF18		
chr1:554484-19673855	19.119	PRAMEF19		
chr1:554484-19673855	19.119	PRAMEF2		
chr1:554484-19673855	19.119	PRAMEF20		
chr1:554484-19673855	19.119	PRAMEF22		
chr1:554484-19673855	19.119	PRAMEF26		
chr1:554484-19673855	19.119	PRAMEF4		
chr1:554484-19673855	19.119	PRAMEF5		
chr1:554484-19673855	19.119	PRAMEF6		
chr1:554484-19673855	19.119	PRAMEF7		
chr1:554484-19673855	19.119	PRAMEF8		
chr1:554484-19673855	19.119	PRAMEF9		
chr1:554484-19673855	19.119	PRDM16	605557	(provisional) Left ventricular noncompaction 8,615373|Cardiomyopathy,dilated,1LL,615373
chr1:554484-19673855	19.119	PRDM2		
chr1:554484-19673855	19.119	PRKCZ		
chr1:554484-19673855	19.119	PUSL1		
chr1:554484-19673855	19.119	RBP7		
chr1:554484-19673855	19.119	RCC2		
chr1:554484-19673855	19.119	RER1		
chr1:554484-19673855	19.119	RERE	605226	(provisional) Neurodevelopmental disorder with or without anomalies of the brain,eye,or heart,616975
chr1:554484-19673855	19.119	RNF207		
chr1:554484-19673855	19.119	RNF223		
chr1:554484-19673855	19.119	RPL22		
chr1:554484-19673855	19.119	RSC1A1		
chr1:554484-19673855	19.119	RSG1		
chr1:554484-19673855	19.119	SAMD11		
chr1:554484-19673855	19.119	SCNN1D		
chr1:554484-19673855	19.119	SDF4		
chr1:554484-19673855	19.119	SDHB	185470	(confirmed) Paragangliomas 4,115310|Pheochromocytoma,171300|Paraganglioma and gastric stromal sarcoma,606864|Cowden syndrome 2,612359|Gastrointestinal stromal tumor,606764
chr1:554484-19673855	19.119	SKI	164780	(confirmed) Shprintzen-Goldberg syndrome,182212
chr1:554484-19673855	19.119	SLC25A33		
chr1:554484-19673855	19.119	SLC25A34		
chr1:554484-19673855	19.119	SLC2A5		
chr1:554484-19673855	19.119	SLC2A7		
chr1:554484-19673855	19.119	SLC35E2		
chr1:554484-19673855	19.119	SLC35E2B		
chr1:554484-19673855	19.119	SLC45A1	605763	(provisional) Intellectual developmental disorder with neuropsychiatric features,617532
chr1:554484-19673855	19.119	SMIM1	615242	(provisional) Blood group,Vel system,615264
chr1:554484-19673855	19.119	SPATA21		
chr1:554484-19673855	19.119	SPEN	606077	(provisional) Megakaryoblastic leukemia,acute
chr1:554484-19673855	19.119	SPSB1		
chr1:554484-19673855	19.119	SRM		
chr1:554484-19673855	19.119	SSU72		
chr1:554484-19673855	19.119	SZRD1		
chr1:554484-19673855	19.119	TARDBP	605078	(confirmed) Amyotrophic lateral sclerosis 10,with or without FTD,612069|Frontotemporal lobar degeneration,TARDBP-related,612069
chr1:554484-19673855	19.119	TAS1R1		
chr1:554484-19673855	19.119	TAS1R2		
chr1:554484-19673855	19.119	TAS1R3		
chr1:554484-19673855	19.119	THAP3		
chr1:554484-19673855	19.119	TMEM201		
chr1:554484-19673855	19.119	TMEM240	616101	(confirmed) Spinocerebellar ataxia 21,607454
chr1:554484-19673855	19.119	TMEM51		
chr1:554484-19673855	19.119	TMEM52		
chr1:554484-19673855	19.119	TMEM82		
chr1:554484-19673855	19.119	TMEM88B		
chr1:554484-19673855	19.119	TNFRSF14		
chr1:554484-19673855	19.119	TNFRSF18		
chr1:554484-19673855	19.119	TNFRSF1B		
chr1:554484-19673855	19.119	TNFRSF25		
chr1:554484-19673855	19.119	TNFRSF4	600315	(provisional) Immunodeficiency 16,615593
chr1:554484-19673855	19.119	TNFRSF8		
chr1:554484-19673855	19.119	TNFRSF9		
chr1:554484-19673855	19.119	TP73	601990	(provisional) Neuroblastoma
chr1:554484-19673855	19.119	TPRG1L		
chr1:554484-19673855	19.119	TTC34		
chr1:554484-19673855	19.119	TTLL10		
chr1:554484-19673855	19.119	UBE2J2		
chr1:554484-19673855	19.119	UBE4B		
chr1:554484-19673855	19.119	UBIAD1	611632	(confirmed) Corneal dystrophy,Schnyder type,121800
chr1:554484-19673855	19.119	UBR4		
chr1:554484-19673855	19.119	UTS2		
chr1:554484-19673855	19.119	VAMP3		
chr1:554484-19673855	19.119	VPS13D		
chr1:554484-19673855	19.119	VWA1		
chr1:554484-19673855	19.119	WRAP73		
chr1:554484-19673855	19.119	ZBTB17		
chr1:554484-19673855	19.119	ZBTB48		
chr4:129214914-140244104	11.029	C4ORF33		
chr4:129214914-140244104	11.029	ELF2		
chr4:129214914-140244104	11.029	JADE1		
chr4:129214914-140244104	11.029	MGARP		
chr4:129214914-140244104	11.029	NAA15		
chr4:129214914-140244104	11.029	NDUFC1		
chr4:129214914-140244104	11.029	NOCT		
chr4:129214914-140244104	11.029	PABPC4L		
chr4:129214914-140244104	11.029	PCDH10		
chr4:129214914-140244104	11.029	PCDH18		
chr4:129214914-140244104	11.029	SCLT1		
chr4:129214914-140244104	11.029	SLC7A11		
chr16:67044324-77632926	10.589	AARS	601065	(confirmed) Charcot-Marie-Tooth disease,axonal,type 2N,613287|Epileptic encephalopathy,early infantile,29,616339
chr16:67044324-77632926	10.589	ACD	609377	(provisional) Dyskeratosis congenita,autosomal dominant 6,616553|Dyskeratosis congenita,autosomal recessive 7,616553
chr16:67044324-77632926	10.589	ADAMTS18	607512	(provisional) Microcornea,myopic chorioretinal atrophy,and telecanthus,615458
chr16:67044324-77632926	10.589	ADAT1		
chr16:67044324-77632926	10.589	AGRP	602311	(provisional) Obesity,late-onset,601665|Leanness,inherited
chr16:67044324-77632926	10.589	AP1G1		
chr16:67044324-77632926	10.589	ATP6V0D1		
chr16:67044324-77632926	10.589	ATXN1L		
chr16:67044324-77632926	10.589	B3GNT9		
chr16:67044324-77632926	10.589	BCAR1		
chr16:67044324-77632926	10.589	C16ORF47		
chr16:67044324-77632926	10.589	C16ORF70		
chr16:67044324-77632926	10.589	C16ORF86		
chr16:67044324-77632926	10.589	CALB2		
chr16:67044324-77632926	10.589	CARMIL2		
chr16:67044324-77632926	10.589	CBFB	121360	(confirmed) Myeloid leukemia,acute,M4/M4Eo subtype,somatic,601626
chr16:67044324-77632926	10.589	CDH1	192090	(confirmed) Endometrial carcinoma,somatic,608089|Ovarian carcinoma,somatic,167000|Breast cancer,lobular,114480|Gastric cancer,familial diffuse,with or without cleft lip and/or palate,137215|Prostate cancer,susceptibility to,176807
chr16:67044324-77632926	10.589	CDH3	114019	(provisional) Mental retardation,autosomal dominant 3,612580
chr16:67044324-77632926	10.589	CENPT		
chr16:67044324-77632926	10.589	CFDP1		
chr16:67044324-77632926	10.589	CHST4		
chr16:67044324-77632926	10.589	CHST5		
chr16:67044324-77632926	10.589	CHST6	605294	(provisional) Macular corneal dystrophy,217800
chr16:67044324-77632926	10.589	CHTF8		
chr16:67044324-77632926	10.589	CLEC18A		
chr16:67044324-77632926	10.589	CLEC18B		
chr16:67044324-77632926	10.589	CLEC18C		
chr16:67044324-77632926	10.589	CMTR2		
chr16:67044324-77632926	10.589	CNTNAP4		
chr16:67044324-77632926	10.589	COG4	606976	(provisional) Congenital disorder of glycosylation,type IIj,613489
chr16:67044324-77632926	10.589	COG8	606979	(confirmed) Congenital disorder of glycosylation,type IIh,611182
chr16:67044324-77632926	10.589	CTCF	604167	(provisional) Mental retardation,autosomal dominant 21,615502
chr16:67044324-77632926	10.589	CTRB1		
chr16:67044324-77632926	10.589	CTRB2		
chr16:67044324-77632926	10.589	CTRL		
chr16:67044324-77632926	10.589	CYB5B		
chr16:67044324-77632926	10.589	DDX19A		
chr16:67044324-77632926	10.589	DDX19B		
chr16:67044324-77632926	10.589	DDX28		
chr16:67044324-77632926	10.589	DHODH	126064	(provisional) Miller syndrome,263750
chr16:67044324-77632926	10.589	DHX38		
chr16:67044324-77632926	10.589	DPEP2		
chr16:67044324-77632926	10.589	DPEP3		
chr16:67044324-77632926	10.589	DUS2		
chr16:67044324-77632926	10.589	E2F4		
chr16:67044324-77632926	10.589	EDC4		
chr16:67044324-77632926	10.589	ELMO3		
chr16:67044324-77632926	10.589	ENKD1		
chr16:67044324-77632926	10.589	ESRP2		
chr16:67044324-77632926	10.589	EXOC3L1		
chr16:67044324-77632926	10.589	EXOSC6		
chr16:67044324-77632926	10.589	FA2H	611026	(provisional) Spastic paraplegia 35,autosomal recessive,612319
chr16:67044324-77632926	10.589	FBXL8		
chr16:67044324-77632926	10.589	FHOD1		
chr16:67044324-77632926	10.589	FUK		
chr16:67044324-77632926	10.589	GABARAPL2		
chr16:67044324-77632926	10.589	GFOD2		
chr16:67044324-77632926	10.589	GLG1		
chr16:67044324-77632926	10.589	HAS3		
chr16:67044324-77632926	10.589	HP	140100	(confirmed) Anhaptoglobinemia,614081|Hypohaptoglobinemia,614081
chr16:67044324-77632926	10.589	HPR		
chr16:67044324-77632926	10.589	HSD11B2	614232	(confirmed) Apparent mineralocorticoid excess,218030
chr16:67044324-77632926	10.589	HSF4	602438	(confirmed) Cataract 5,multiple types,116800
chr16:67044324-77632926	10.589	HYDIN	610812	(confirmed) Ciliary dyskinesia,primary,5,608647
chr16:67044324-77632926	10.589	IL34		
chr16:67044324-77632926	10.589	IST1		
chr16:67044324-77632926	10.589	KARS	601421	(confirmed) Charcot-Marie-Tooth disease,recessive intermediate,B,613641|Deafness,autosomal recessive 89,613916
chr16:67044324-77632926	10.589	KCTD19		
chr16:67044324-77632926	10.589	KIAA0895L		
chr16:67044324-77632926	10.589	LCAT	606967	(confirmed) Norum disease,245900|Fish-eye disease,136120
chr16:67044324-77632926	10.589	LDHD		
chr16:67044324-77632926	10.589	LRRC29		
chr16:67044324-77632926	10.589	LRRC36		
chr16:67044324-77632926	10.589	MARVELD3		
chr16:67044324-77632926	10.589	MLKL		
chr16:67044324-77632926	10.589	MON1B		
chr16:67044324-77632926	10.589	MTSS1L		
chr16:67044324-77632926	10.589	NFAT5		
chr16:67044324-77632926	10.589	NFATC3		
chr16:67044324-77632926	10.589	NIP7		
chr16:67044324-77632926	10.589	NOB1		
chr16:67044324-77632926	10.589	NOL3	605235	(provisional) Myoclonus,familial cortical,614937
chr16:67044324-77632926	10.589	NPIPB15		
chr16:67044324-77632926	10.589	NQO1	125860	(confirmed) Benzene toxicity,susceptibility to|Leukemia,post-chemotherapy,susceptibility to|Breast cancer,poor survival after chemotherapy for
chr16:67044324-77632926	10.589	NRN1L		
chr16:67044324-77632926	10.589	NUTF2		
chr16:67044324-77632926	10.589	PARD6A		
chr16:67044324-77632926	10.589	PDF		
chr16:67044324-77632926	10.589	PDPR		
chr16:67044324-77632926	10.589	PHLPP2		
chr16:67044324-77632926	10.589	PLA2G15		
chr16:67044324-77632926	10.589	PLEKHG4		
chr16:67044324-77632926	10.589	PMFBP1		
chr16:67044324-77632926	10.589	PRMT7	610087	(provisional) Short stature,brachydactyly,intellectual developmental disability,and seizures,617157
chr16:67044324-77632926	10.589	PSKH1		
chr16:67044324-77632926	10.589	PSMB10		
chr16:67044324-77632926	10.589	PSMD7		
chr16:67044324-77632926	10.589	RANBP10		
chr16:67044324-77632926	10.589	RFWD3		
chr16:67044324-77632926	10.589	RIPOR1		
chr16:67044324-77632926	10.589	SF3B3		
chr16:67044324-77632926	10.589	SLC12A4		
chr16:67044324-77632926	10.589	SLC7A6		
chr16:67044324-77632926	10.589	SLC7A6OS		
chr16:67044324-77632926	10.589	SLC9A5		
chr16:67044324-77632926	10.589	SMPD3		
chr16:67044324-77632926	10.589	SNTB2		
chr16:67044324-77632926	10.589	ST3GAL2		
chr16:67044324-77632926	10.589	SYCE1L		
chr16:67044324-77632926	10.589	TANGO6		
chr16:67044324-77632926	10.589	TAT	613018	(confirmed) Tyrosinemia,type II,276600
chr16:67044324-77632926	10.589	TERF2		
chr16:67044324-77632926	10.589	TERF2IP		
chr16:67044324-77632926	10.589	THAP11		
chr16:67044324-77632926	10.589	TMED6		
chr16:67044324-77632926	10.589	TMEM170A		
chr16:67044324-77632926	10.589	TMEM208		
chr16:67044324-77632926	10.589	TMEM231	614949	(provisional) Joubert syndrome 20,614970|Meckel syndrome 11,615397
chr16:67044324-77632926	10.589	TPPP3		
chr16:67044324-77632926	10.589	TRADD		
chr16:67044324-77632926	10.589	TSNAXIP1		
chr16:67044324-77632926	10.589	TXNL4B		
chr16:67044324-77632926	10.589	UTP4		
chr16:67044324-77632926	10.589	VAC14	604632	(provisional) Striatonigral degeneration,childhood-onset,617054
chr16:67044324-77632926	10.589	VPS4A		
chr16:67044324-77632926	10.589	WDR59		
chr16:67044324-77632926	10.589	WWP2		
chr16:67044324-77632926	10.589	ZDHHC1		
chr16:67044324-77632926	10.589	ZFHX3	104155	(confirmed) Prostate cancer,susceptibility to,somatic,176807
chr16:67044324-77632926	10.589	ZFP1		
chr16:67044324-77632926	10.589	ZFP90		
chr16:67044324-77632926	10.589	ZNF19		
chr16:67044324-77632926	10.589	ZNF23		
chr16:67044324-77632926	10.589	ZNF821		
chr16:67044324-77632926	10.589	ZNRF1		
chr7:90710692-101163134	10.452	ACHE	100740	(confirmed) Blood group,Yt system,112100
chr7:90710692-101163134	10.452	ACTL6B		
chr7:90710692-101163134	10.452	AGFG2		
chr7:90710692-101163134	10.452	AKAP9	604001	(provisional) Long QT syndrome-11,611820
chr7:90710692-101163134	10.452	ANKIB1		
chr7:90710692-101163134	10.452	AP1S1	603531	(provisional) MEDNIK syndrome,609313
chr7:90710692-101163134	10.452	AP4M1	602296	(confirmed) Spastic paraplegia 50,autosomal recessive,612936
chr7:90710692-101163134	10.452	ARPC1A		
chr7:90710692-101163134	10.452	ARPC1B		
chr7:90710692-101163134	10.452	ASB4		
chr7:90710692-101163134	10.452	ASNS	108370	(confirmed) Asparagine synthetase deficiency,615574
chr7:90710692-101163134	10.452	ATP5J2		
chr7:90710692-101163134	10.452	ATP5J2-PTCD1		
chr7:90710692-101163134	10.452	AZGP1		
chr7:90710692-101163134	10.452	BAIAP2L1		
chr7:90710692-101163134	10.452	BET1		
chr7:90710692-101163134	10.452	BHLHA15		
chr7:90710692-101163134	10.452	BRI3		
chr7:90710692-101163134	10.452	BUD31		
chr7:90710692-101163134	10.452	C7ORF43		
chr7:90710692-101163134	10.452	C7ORF61		
chr7:90710692-101163134	10.452	CALCR	114131	(confirmed) Osteoporosis,postmenopausal,susceptibility,166710
chr7:90710692-101163134	10.452	CASD1		
chr7:90710692-101163134	10.452	CDK14		
chr7:90710692-101163134	10.452	CDK6	603368	(confirmed) Microcephaly 12,primary,autosomal recessive,616080
chr7:90710692-101163134	10.452	CLDN15		
chr7:90710692-101163134	10.452	CNPY4		
chr7:90710692-101163134	10.452	COL1A2	120160	(confirmed) Ehlers-Danlos syndrome,type VIIB,130060|Osteogenesis imperfecta,type IV,166220|Osteogenesis imperfecta,type III,259420|Osteogenesis imperfecta,type II,166210|Osteoporosis,postmenopausal,166710|Ehlers-Danlos syndrome,cardiac valvular form,225320
chr7:90710692-101163134	10.452	COL26A1		
chr7:90710692-101163134	10.452	COPS6		
chr7:90710692-101163134	10.452	CPSF4		
chr7:90710692-101163134	10.452	CYP3A4		
chr7:90710692-101163134	10.452	CYP3A43		
chr7:90710692-101163134	10.452	CYP3A5	605325	(confirmed) Hypertension,salt-sensitive essential,susceptibility to,145500
chr7:90710692-101163134	10.452	CYP3A7		
chr7:90710692-101163134	10.452	CYP51A1		
chr7:90710692-101163134	10.452	DLX5	600028	(confirmed) Split-hand/foot malformation 1 with sensorineural hearing loss,220600
chr7:90710692-101163134	10.452	DLX6		
chr7:90710692-101163134	10.452	DYNC1I1		
chr7:90710692-101163134	10.452	EPHB4	600011	(provisional) Hydrops fetalis,nonimmune,and/or atrial septal defect,617300
chr7:90710692-101163134	10.452	EPO	133170	(confirmed) Microvascular complications of diabetes 2,612623
chr7:90710692-101163134	10.452	ERVW-1		
chr7:90710692-101163134	10.452	FAM133B		
chr7:90710692-101163134	10.452	FAM200A		
chr7:90710692-101163134	10.452	FBXO24		
chr7:90710692-101163134	10.452	FIS1		
chr7:90710692-101163134	10.452	FZD1		
chr7:90710692-101163134	10.452	GAL3ST4		
chr7:90710692-101163134	10.452	GATAD1	614518	(provisional) Cardiomyopathy,dilated,2B,614672
chr7:90710692-101163134	10.452	GATS		
chr7:90710692-101163134	10.452	GIGYF1		
chr7:90710692-101163134	10.452	GJC3		
chr7:90710692-101163134	10.452	GNB2		
chr7:90710692-101163134	10.452	GNG11		
chr7:90710692-101163134	10.452	GNGT1		
chr7:90710692-101163134	10.452	GPC2		
chr7:90710692-101163134	10.452	HEPACAM2		
chr7:90710692-101163134	10.452	IFT22		
chr7:90710692-101163134	10.452	KPNA7		
chr7:90710692-101163134	10.452	KRIT1	604214	(confirmed) Cerebral cavernous malformations-1,116860|Hyperkeratotic cutaneous capillary-venous malformations associated with cerebral capillary malformations,116860|Cavernous malformations of CNS and retina,116860
chr7:90710692-101163134	10.452	LAMTOR4		
chr7:90710692-101163134	10.452	LMTK2		
chr7:90710692-101163134	10.452	LRCH4		
chr7:90710692-101163134	10.452	LRRD1		
chr7:90710692-101163134	10.452	MBLAC1		
chr7:90710692-101163134	10.452	MCM7		
chr7:90710692-101163134	10.452	MEPCE		
chr7:90710692-101163134	10.452	MOGAT3		
chr7:90710692-101163134	10.452	MOSPD3		
chr7:90710692-101163134	10.452	MTERF1		
chr7:90710692-101163134	10.452	MUC12		
chr7:90710692-101163134	10.452	MUC17		
chr7:90710692-101163134	10.452	MUC3A		
chr7:90710692-101163134	10.452	NAT16		
chr7:90710692-101163134	10.452	NPTX2		
chr7:90710692-101163134	10.452	NYAP1		
chr7:90710692-101163134	10.452	OCM2		
chr7:90710692-101163134	10.452	OR2AE1		
chr7:90710692-101163134	10.452	PAI1	173360	(confirmed) Plasminogen activator inhibitor-1 deficiency,613329|Transcription of plasminogen activator inhibitor,modulator of
chr7:90710692-101163134	10.452	PCOLCE		
chr7:90710692-101163134	10.452	PDAP1		
chr7:90710692-101163134	10.452	PDK4		
chr7:90710692-101163134	10.452	PEG10		
chr7:90710692-101163134	10.452	PEX1	602136	(confirmed) Peroxisome biogenesis disorder 1A (Zellweger),214100|Peroxisome biogenesis disorder 1B (NALD/IRD),601539|Heimler syndrome 1,234580
chr7:90710692-101163134	10.452	PILRA		
chr7:90710692-101163134	10.452	PILRB		
chr7:90710692-101163134	10.452	PLOD3	603066	(provisional) Lysyl hydroxylase 3 deficiency,612394
chr7:90710692-101163134	10.452	PON1	168820	(confirmed) Coronary artery disease,susceptibility to|Coronary artery spasm 2,susceptibility to|Organophosphate poisoning,sensitivity to|Microvascular complications of diabetes 5,612633
chr7:90710692-101163134	10.452	PON2	602447	(confirmed) Coronary artery disease,susceptibility to
chr7:90710692-101163134	10.452	PON3		
chr7:90710692-101163134	10.452	POP7		
chr7:90710692-101163134	10.452	PPP1R35		
chr7:90710692-101163134	10.452	PPP1R9A		
chr7:90710692-101163134	10.452	PTCD1		
chr7:90710692-101163134	10.452	PVRIG		
chr7:90710692-101163134	10.452	RBM48		
chr7:90710692-101163134	10.452	SAMD9	610456	(confirmed) Tumoral calcinosis,familial,normophosphatemic,610455|MIRAGE syndrome,617053
chr7:90710692-101163134	10.452	SAMD9L	611170	(provisional) Ataxia-pancytopenia syndrome,159550
chr7:90710692-101163134	10.452	SAP25		
chr7:90710692-101163134	10.452	SDHAF3		
chr7:90710692-101163134	10.452	SEM1		
chr7:90710692-101163134	10.452	SERPINE1	173360	(confirmed) Plasminogen activator inhibitor-1 deficiency,613329|Transcription of plasminogen activator inhibitor,modulator of
chr7:90710692-101163134	10.452	SGCE	604149	(confirmed) Dystonia-11,myoclonic,159900
chr7:90710692-101163134	10.452	SHFM1	183600	(confirmed) Split hand/foot malformation 1
chr7:90710692-101163134	10.452	SLC12A9		
chr7:90710692-101163134	10.452	SLC25A13	603859	(provisional) Citrullinemia,adult-onset type II,603471|Citrullinemia,type II,neonatal-onset,605814
chr7:90710692-101163134	10.452	SMURF1		
chr7:90710692-101163134	10.452	SPDYE3		
chr7:90710692-101163134	10.452	SRRT		
chr7:90710692-101163134	10.452	STAG3	608489	(provisional) Premature ovarian failure 8,615723
chr7:90710692-101163134	10.452	TAC1		
chr7:90710692-101163134	10.452	TAF6	602955	(provisional) Alazami-Yuan syndrome,617126
chr7:90710692-101163134	10.452	TECPR1		
chr7:90710692-101163134	10.452	TFPI2		
chr7:90710692-101163134	10.452	TFR2	604720	(provisional) Hemochromatosis,type 3,604250
chr7:90710692-101163134	10.452	TMEM130		
chr7:90710692-101163134	10.452	TRIM4		
chr7:90710692-101163134	10.452	TRIM56		
chr7:90710692-101163134	10.452	TRIP6		
chr7:90710692-101163134	10.452	TRRAP		
chr7:90710692-101163134	10.452	TSC22D4		
chr7:90710692-101163134	10.452	UFSP1		
chr7:90710692-101163134	10.452	VGF		
chr7:90710692-101163134	10.452	VPS50		
chr7:90710692-101163134	10.452	ZAN		
chr7:90710692-101163134	10.452	ZCWPW1		
chr7:90710692-101163134	10.452	ZKSCAN1		
chr7:90710692-101163134	10.452	ZKSCAN5		
chr7:90710692-101163134	10.452	ZNF3		
chr7:90710692-101163134	10.452	ZNF394		
chr7:90710692-101163134	10.452	ZNF655		
chr7:90710692-101163134	10.452	ZNF789		
chr7:90710692-101163134	10.452	ZNHIT1		
chr7:90710692-101163134	10.452	ZSCAN21		
chr7:90710692-101163134	10.452	ZSCAN25		
chr5:170171690-176658608	6.487	ARL10		
chr5:170171690-176658608	6.487	ATP6V0E1		
chr5:170171690-176658608	6.487	BNIP1		
chr5:170171690-176658608	6.487	BOD1		
chr5:170171690-176658608	6.487	C5ORF47		
chr5:170171690-176658608	6.487	CDHR2		
chr5:170171690-176658608	6.487	CLTB		
chr5:170171690-176658608	6.487	CPEB4		
chr5:170171690-176658608	6.487	CPLX2		
chr5:170171690-176658608	6.487	CREBRF		
chr5:170171690-176658608	6.487	DRD1		
chr5:170171690-176658608	6.487	DUSP1		
chr5:170171690-176658608	6.487	EFCAB9		
chr5:170171690-176658608	6.487	EIF4E1B		
chr5:170171690-176658608	6.487	ERGIC1		
chr5:170171690-176658608	6.487	FAF2		
chr5:170171690-176658608	6.487	FAM153B		
chr5:170171690-176658608	6.487	FBXW11		
chr5:170171690-176658608	6.487	FGF18		
chr5:170171690-176658608	6.487	FGFR4	134935	(confirmed) Cancer progression/metastasis
chr5:170171690-176658608	6.487	GABRP		
chr5:170171690-176658608	6.487	GPRIN1		
chr5:170171690-176658608	6.487	HIGD2A		
chr5:170171690-176658608	6.487	HK3		
chr5:170171690-176658608	6.487	HRH2		
chr5:170171690-176658608	6.487	KIAA1191		
chr5:170171690-176658608	6.487	MSX2	123101	(confirmed) Craniosynostosis 2,604757|Parietal foramina 1,168500|Parietal foramina with cleidocranial dysplasia,168550
chr5:170171690-176658608	6.487	NEURL1B		
chr5:170171690-176658608	6.487	NKX2-5	600584	(confirmed) Atrial septal defect 7,with or without AV conduction defects,108900|Tetralogy of Fallot,187500|Hypothyroidism,congenital nongoitrous,5,225250|Ventricular septal defect 3,614432|Hypoplastic left heart syndrome 2,614435|Conotruncal heart malformations,variable,217095
chr5:170171690-176658608	6.487	NOP16		
chr5:170171690-176658608	6.487	NPM1	164040	(provisional) Leukemia,acute myeloid,somatic,601626
chr5:170171690-176658608	6.487	NSD1	606681	(confirmed) Sotos syndrome 1,117550|Leukemia,acute myeloid,601626|Beckwith-Wiedemann syndrome,130650
chr5:170171690-176658608	6.487	NSG2		
chr5:170171690-176658608	6.487	RANBP17		
chr5:170171690-176658608	6.487	RNF44		
chr5:170171690-176658608	6.487	RPL26L1		
chr5:170171690-176658608	6.487	SFXN1		
chr5:170171690-176658608	6.487	SH3PXD2B	613293	(provisional) Frank-ter Haar syndrome,249420
chr5:170171690-176658608	6.487	SIMC1		
chr5:170171690-176658608	6.487	SMIM23		
chr5:170171690-176658608	6.487	SNCB	602569	(provisional) Dementia,Lewy body,127750
chr5:170171690-176658608	6.487	STC2		
chr5:170171690-176658608	6.487	STK10		
chr5:170171690-176658608	6.487	THOC3		
chr5:170171690-176658608	6.487	TLX3		
chr5:170171690-176658608	6.487	TSPAN17		
chr5:170171690-176658608	6.487	UBTD2		
chr5:170171690-176658608	6.487	UIMC1		
chr5:170171690-176658608	6.487	UNC5A		
chr5:170171690-176658608	6.487	ZNF346		
chr15:70991539-76520785	5.529	ADPGK		
chr15:70991539-76520785	5.529	ARID3B		
chr15:70991539-76520785	5.529	ARIH1		
chr15:70991539-76520785	5.529	BBS4	600374	(confirmed) Bardet-Biedl syndrome 4,615982
chr15:70991539-76520785	5.529	C15ORF39		
chr15:70991539-76520785	5.529	C15ORF59		
chr15:70991539-76520785	5.529	CCDC33		
chr15:70991539-76520785	5.529	CD276		
chr15:70991539-76520785	5.529	CELF6		
chr15:70991539-76520785	5.529	CLK3		
chr15:70991539-76520785	5.529	COMMD4		
chr15:70991539-76520785	5.529	COX5A		
chr15:70991539-76520785	5.529	CPLX3		
chr15:70991539-76520785	5.529	CSK		
chr15:70991539-76520785	5.529	CSPG4		
chr15:70991539-76520785	5.529	CT62		
chr15:70991539-76520785	5.529	CYP11A1	118485	(confirmed) Adrenal insufficiency,congenital,with 46XY sex reversal,partial or complete,613743
chr15:70991539-76520785	5.529	CYP1A1		
chr15:70991539-76520785	5.529	CYP1A2		
chr15:70991539-76520785	5.529	EDC3	609842	(provisional) Mental retardation,autosomal recessive 50,616460
chr15:70991539-76520785	5.529	ETFA	608053	(confirmed) Glutaric acidemia IIA,231680
chr15:70991539-76520785	5.529	FAM219B		
chr15:70991539-76520785	5.529	FBXO22		
chr15:70991539-76520785	5.529	GOLGA6A		
chr15:70991539-76520785	5.529	GOLGA6B		
chr15:70991539-76520785	5.529	GOLGA6C		
chr15:70991539-76520785	5.529	GOLGA6D		
chr15:70991539-76520785	5.529	GRAMD2A		
chr15:70991539-76520785	5.529	HCN4	605206	(provisional) Sick sinus syndrome 2,163800|Brugada syndrome 8,613123
chr15:70991539-76520785	5.529	HEXA	606869	(confirmed) Tay-Sachs disease,272800|GM2-gangliosidosis,several forms,272800|Hex A pseudodeficiency,272800
chr15:70991539-76520785	5.529	HIGD2B		
chr15:70991539-76520785	5.529	IMP3		
chr15:70991539-76520785	5.529	ISLR		
chr15:70991539-76520785	5.529	ISLR2		
chr15:70991539-76520785	5.529	LARP6		
chr15:70991539-76520785	5.529	LMAN1L		
chr15:70991539-76520785	5.529	LOXL1	153456	(confirmed) Exfoliation syndrome,susceptibility to,177650
chr15:70991539-76520785	5.529	LRRC49		
chr15:70991539-76520785	5.529	MAN2C1		
chr15:70991539-76520785	5.529	MPI	154550	(confirmed) Congenital disorder of glycosylation,type Ib,602579
chr15:70991539-76520785	5.529	MYO9A		
chr15:70991539-76520785	5.529	NEIL1		
chr15:70991539-76520785	5.529	NEO1		
chr15:70991539-76520785	5.529	NPTN		
chr15:70991539-76520785	5.529	NR2E3	604485	(confirmed) Enhanced S-cone syndrome,268100|Retinitis pigmentosa 37,611131
chr15:70991539-76520785	5.529	NRG4		
chr15:70991539-76520785	5.529	ODF3L1		
chr15:70991539-76520785	5.529	PARP6		
chr15:70991539-76520785	5.529	PKM		
chr15:70991539-76520785	5.529	PML	102578	(confirmed) Leukemia,acute promyelocytic,PML/RARA type
chr15:70991539-76520785	5.529	PPCDC		
chr15:70991539-76520785	5.529	PTPN9		
chr15:70991539-76520785	5.529	REC114		
chr15:70991539-76520785	5.529	RPP25		
chr15:70991539-76520785	5.529	SCAMP2		
chr15:70991539-76520785	5.529	SCAMP5		
chr15:70991539-76520785	5.529	SEMA7A	607961	(confirmed) Blood group,John-Milton-Hagen system,614745
chr15:70991539-76520785	5.529	SENP8		
chr15:70991539-76520785	5.529	SIN3A	607776	(provisional) Witteveen-Kolk syndrome,613406
chr15:70991539-76520785	5.529	SNUPN		
chr15:70991539-76520785	5.529	SNX33		
chr15:70991539-76520785	5.529	STOML1		
chr15:70991539-76520785	5.529	STRA6	610745	(provisional) Microphthalmia,syndromic 9,601186|Microphthalmia,isolated,with coloboma 8,601186
chr15:70991539-76520785	5.529	TBC1D21		
chr15:70991539-76520785	5.529	THAP10		
chr15:70991539-76520785	5.529	THSD4		
chr15:70991539-76520785	5.529	TMEM202		
chr15:70991539-76520785	5.529	TMEM266		
chr15:70991539-76520785	5.529	UACA		
chr15:70991539-76520785	5.529	UBE2Q2		
chr15:70991539-76520785	5.529	UBL7		
chr15:70991539-76520785	5.529	ULK3		
chr15:46114468-49530477	3.416	CEP152	613529	(provisional) Microcephaly 9,primary,autosomal recessive,614852|Seckel syndrome 5,613823
chr15:46114468-49530477	3.416	COPS2		
chr15:46114468-49530477	3.416	CTXN2		
chr15:46114468-49530477	3.416	DUT		
chr15:46114468-49530477	3.416	EID1		
chr15:46114468-49530477	3.416	FBN1	134797	(confirmed) Marfan syndrome,154700|Marfan lipodystrophy syndrome,616914|Ectopia lentis,familial,129600|MASS syndrome,604308|Weill-Marchesani syndrome 2,dominant,608328|Stiff skin syndrome,184900|Acromicric dysplasia,102370|Geleophysic dysplasia 2,614185
chr15:46114468-49530477	3.416	GALK2		
chr15:46114468-49530477	3.416	MYEF2		
chr15:46114468-49530477	3.416	SECISBP2L		
chr15:46114468-49530477	3.416	SEMA6D		
chr15:46114468-49530477	3.416	SHC4		
chr15:46114468-49530477	3.416	SLC12A1	600839	(confirmed) Bartter syndrome,type 1,601678
chr15:46114468-49530477	3.416	SLC24A5	609802	(provisional) Skin/hair/eye pigmentation 4,fair/dark skin,113750|Albinism,oculocutaneous,type VI,113750
chr5:89344-3214324	3.125	AHRR		
chr5:89344-3214324	3.125	BRD9		
chr5:89344-3214324	3.125	C5ORF38		
chr5:89344-3214324	3.125	CCDC127		
chr5:89344-3214324	3.125	CEP72		
chr5:89344-3214324	3.125	CLPTM1L		
chr5:89344-3214324	3.125	EXOC3		
chr5:89344-3214324	3.125	EXOC3-AS1		
chr5:89344-3214324	3.125	IRX2		
chr5:89344-3214324	3.125	IRX4		
chr5:89344-3214324	3.125	LPCAT1		
chr5:89344-3214324	3.125	LRRC14B		
chr5:89344-3214324	3.125	MRPL36		
chr5:89344-3214324	3.125	NDUFS6	603848	(provisional) Mitochondrial complex I deficiency,252010
chr5:89344-3214324	3.125	NKD2		
chr5:89344-3214324	3.125	PDCD6		
chr5:89344-3214324	3.125	PLEKHG4B		
chr5:89344-3214324	3.125	SDHA	600857	(confirmed) Leigh syndrome,256000|Mitochondrial respiratory chain complex II deficiency,252011|Cardiomyopathy,dilated,1GG,613642|Paragangliomas 5,614165
chr5:89344-3214324	3.125	SLC12A7		
chr5:89344-3214324	3.125	SLC6A18		
chr5:89344-3214324	3.125	SLC6A19	608893	(confirmed) Hartnup disorder,234500|Iminoglycinuria,digenic,242600|Hyperglycinuria,138500
chr5:89344-3214324	3.125	SLC6A3	126455	(confirmed) Nicotine dependence,protection against,188890|Parkinsonism-dystonia,infantile,613135
chr5:89344-3214324	3.125	SLC9A3	182307	(confirmed) Diarrhea 8,secretory sodium,congenital,616868
chr5:89344-3214324	3.125	TERT	187270	(confirmed) Pulmonary fibrosis and/or bone marrow failure,telomere-related,1,614742|Dyskeratosis congenita,autosomal recessive 4,613989|Dyskeratosis congenita,autosomal dominant 2,613989|Leukemia,acute myeloid,601626|Melanoma,cutaneous malignant,9,615134
chr5:89344-3214324	3.125	TPPP		
chr5:89344-3214324	3.125	TRIP13		
chr5:89344-3214324	3.125	ZDHHC11		
chr5:89344-3214324	3.125	ZDHHC11B		
chr8:7825131-10920490	3.095	C8ORF74		
chr8:7825131-10920490	3.095	CLDN23		
chr8:7825131-10920490	3.095	ERI1		
chr8:7825131-10920490	3.095	MFHAS1	605352	(provisional) Malignant fibrous histiocytoma
chr8:7825131-10920490	3.095	MSRA		
chr8:7825131-10920490	3.095	PINX1		
chr8:7825131-10920490	3.095	PPP1R3B		
chr8:7825131-10920490	3.095	PRAG1		
chr8:7825131-10920490	3.095	PRSS55		
chr8:7825131-10920490	3.095	RP1L1	608581	(confirmed) Occult macular dystrophy,613587
chr8:7825131-10920490	3.095	SOX7		
chr8:7825131-10920490	3.095	TNKS		
chr8:7825131-10920490	3.095	XKR6		
chr12:36144018-38586239	2.442			
chr3:74950107-76702737	1.753	FRG2C		
chr3:74950107-76702737	1.753	ROBO2	602431	(provisional) Vesicoureteral reflux 2,610878
chr3:74950107-76702737	1.753	ZNF717		
chrX:121552909-123268848	1.716	GRIA3	305915	(confirmed) Mental retardation,X-linked 94,300699
chrX:121552909-123268848	1.716	STAG2		
chrX:121552909-123268848	1.716	THOC2	300395	(provisional) Mental retardation,X-linked 12/35,300957
chrX:121552909-123268848	1.716	XIAP	300079	(confirmed) Lymphoproliferative syndrome,X-linked,2,300635
chr5:177833371-179514581	1.681	ADAMTS2	604539	(provisional) Ehlers-Danlos syndrome,type VIIC,225410
chr5:177833371-179514581	1.681	C5ORF60		
chr5:177833371-179514581	1.681	CANX		
chr5:177833371-179514581	1.681	CBY3		
chr5:177833371-179514581	1.681	CLK4		
chr5:177833371-179514581	1.681	COL23A1		
chr5:177833371-179514581	1.681	GRM6	604096	(confirmed) Night blindness,congenital stationary (complete),1B,autosomal recessive,257270
chr5:177833371-179514581	1.681	HNRNPH1		
chr5:177833371-179514581	1.681	LTC4S	246530	(provisional) Leukotriene C4 synthase deficiency,614037
chr5:177833371-179514581	1.681	MAML1		
chr5:177833371-179514581	1.681	MGAT4B		
chr5:177833371-179514581	1.681	MRNIP		
chr5:177833371-179514581	1.681	RNF130		
chr5:177833371-179514581	1.681	RUFY1		
chr5:177833371-179514581	1.681	SQSTM1	601530	(confirmed) Paget disease of bone 3,167250|Frontotemporal dementia and/or amyotrophic lateral sclerosis 3,616437|Neurodegeneration with ataxia,dystonia,and gaze palsy,childhood-onset,617145|Myopathy,distal,with rimmed vacuoles,617158
chr5:177833371-179514581	1.681	TBC1D9B		
chr5:177833371-179514581	1.681	ZFP2		
chr5:177833371-179514581	1.681	ZNF354A		
chr5:177833371-179514581	1.681	ZNF354B		
chr5:177833371-179514581	1.681	ZNF354C		
chr5:177833371-179514581	1.681	ZNF454		
chr5:177833371-179514581	1.681	ZNF879		
chr2:146374072-147959333	1.585			
chr19:41956174-43297276	1.341	ARHGEF1		
chr19:41956174-43297276	1.341	ATP1A3	182350	(confirmed) Dystonia-12,128235|Alternating hemiplegia of childhood 2,614820|CAPOS syndrome,601338
chr19:41956174-43297276	1.341	CD79A	112205	(provisional) Agammaglobulinemia 3,613501
chr19:41956174-43297276	1.341	CEACAM1		
chr19:41956174-43297276	1.341	CEACAM21		
chr19:41956174-43297276	1.341	CEACAM3		
chr19:41956174-43297276	1.341	CEACAM4		
chr19:41956174-43297276	1.341	CEACAM5		
chr19:41956174-43297276	1.341	CEACAM6		
chr19:41956174-43297276	1.341	CEACAM7		
chr19:41956174-43297276	1.341	CEACAM8		
chr19:41956174-43297276	1.341	CIC		
chr19:41956174-43297276	1.341	CNFN		
chr19:41956174-43297276	1.341	CXCL17		
chr19:41956174-43297276	1.341	DEDD2		
chr19:41956174-43297276	1.341	DMRTC2		
chr19:41956174-43297276	1.341	ERF	611888	(confirmed) Craniosynostosis 4,600775|Chitayat syndrome,617180
chr19:41956174-43297276	1.341	GRIK5		
chr19:41956174-43297276	1.341	GSK3A		
chr19:41956174-43297276	1.341	LIPE	151750	(confirmed) Lipodystrophy,familial partial,type 6,615980
chr19:41956174-43297276	1.341	LYPD4		
chr19:41956174-43297276	1.341	MEGF8	604267	(provisional) Carpenter syndrome 2,614976
chr19:41956174-43297276	1.341	PAFAH1B3		
chr19:41956174-43297276	1.341	POU2F2		
chr19:41956174-43297276	1.341	PRR19		
chr19:41956174-43297276	1.341	PSG3		
chr19:41956174-43297276	1.341	PSG8		
chr19:41956174-43297276	1.341	RABAC1		
chr19:41956174-43297276	1.341	RPS19	603474	(confirmed) Diamond-Blackfan anemia 1,105650
chr19:41956174-43297276	1.341	TMEM145		
chr19:41956174-43297276	1.341	ZNF526		
chr19:41956174-43297276	1.341	ZNF574		
chr21:13291078-14560469	1.269			
chr8:112404826-113655404	1.251	CSMD3		
chr22:26515452-27651008	1.136	ASPHD2		
chr22:26515452-27651008	1.136	CRYBA4	123631	(confirmed) Cataract 23,610425
chr22:26515452-27651008	1.136	CRYBB1	600929	(provisional) Cataract 17,multiple types,611544
chr22:26515452-27651008	1.136	HPS4	606682	(provisional) Hermansky-Pudlak syndrome 4,614073
chr22:26515452-27651008	1.136	MIAT	611082	(provisional) Myocardial infarction,susceptibility to,608446
chr22:26515452-27651008	1.136	SEZ6L		
chr22:26515452-27651008	1.136	SRRD		
chr22:26515452-27651008	1.136	TFIP11		
chr22:26515452-27651008	1.136	TPST2		
chr4:126595623-127678694	1.083			
chr13:62888254-63957309	1.069			
chr5:127343595-128367750	1.024	FBN2	612570	(provisional) Contractural arachnodactyly,congenital,121050|Macular degeneration,early-onset,616118
chr5:127343595-128367750	1.024	SLC12A2		
chr5:127343595-128367750	1.024	SLC27A6		
chr8:83970765-84991847	1.021			
chr12:121870927-122885054	1.014	B3GNT4		
chr12:121870927-122885054	1.014	BCL7A	601406	(provisional) B-cell non-Hodgkin lymphoma,high-grade
chr12:121870927-122885054	1.014	CLIP1		
chr12:121870927-122885054	1.014	DIABLO	605219	(provisional) Deafness,autosomal dominant 64,614152
chr12:121870927-122885054	1.014	HPD	609695	(confirmed) Tyrosinemia,type III,276710|Hawkinsinuria,140350
chr12:121870927-122885054	1.014	IL31		
chr12:121870927-122885054	1.014	KDM2B		
chr12:121870927-122885054	1.014	LRRC43		
chr12:121870927-122885054	1.014	MLXIP		
chr12:121870927-122885054	1.014	MORN3		
chr12:121870927-122885054	1.014	ORAI1	610277	(provisional) Immunodeficiency 9,612782|Myopathy,tubular aggregate,2,615883
chr12:121870927-122885054	1.014	PSMD9		
chr12:121870927-122885054	1.014	RHOF		
chr12:121870927-122885054	1.014	SETD1B		
chr12:121870927-122885054	1.014	TMEM120B		
chr12:121870927-122885054	1.014	VPS33A	610034	(provisional) Mucopolysaccharidosis-plus syndrome,617303
chr12:121870927-122885054	1.014	WDR66		
chrX:103490616-104239251	0.749	ESX1		
chrX:103490616-104239251	0.749	IL1RAPL2		
chrX:72817077-73500436	0.683	CHIC1		
chrX:72817077-73500436	0.683	XIST	314670	(confirmed) X-inactivation,familial skewed,300087
chrX:49809049-50400324	0.591	AKAP4		
chrX:49809049-50400324	0.591	CCNB3		
chrX:49809049-50400324	0.591	CLCN5	300008	(confirmed) Dent disease,300009|Nephrolithiasis,type I,310468|Hypophosphatemic rickets,300554|Proteinuria,low molecular weight,with hypercalciuric nephrocalcinosis,308990
chrX:49809049-50400324	0.591	SHROOM4	300579	(confirmed) Stocco dos Santos X-linked mental retardation syndrome,300434
chr1:187447779-187954827	0.507			
chr17:55053802-55559628	0.506	AKAP1		
chr17:55053802-55559628	0.506	MSI2		
chr17:55053802-55559628	0.506	SCPEP1		
chr2:156049880-156525956	0.476			
chr5:129583658-130023111	0.439			
chr16:64842787-65163497	0.321	CDH11		
chrX:115765840-116073314	0.307			
chr4:96983809-97222664	0.239			
chr5:131601293-131800296	0.199	C5ORF56		
chr5:131601293-131800296	0.199	IRF1	147575	(confirmed) Myelodysplastic syndrome,preleukemic|Myelogenous leukemia,acute|Gastric cancer,somatic,613659|Nonsmall cell lung cancer,somatic,211980
chr5:131601293-131800296	0.199	PDLIM4	603422	(provisional) Osteoporosis,susceptibility to,166710
chr5:131601293-131800296	0.199	SLC22A4	604190	(provisional) Rheumatoid arthritis,susceptibility to,180300
chr5:131601293-131800296	0.199	SLC22A5	603377	(confirmed) Carnitine deficiency,systemic primary,212140
chr14:45429031-45599844	0.171	FKBP3		
chr14:45429031-45599844	0.171	KLHL28		
chr14:45429031-45599844	0.171	PRPF39		
chr14:45429031-45599844	0.171	TOGARAM1		
chr4:108240049-108384277	0.144			
chrX:112746094-112886327	0.140			
chrX:99587433-99724479	0.137	PCDH19	300460	(confirmed) Epileptic encephalopathy,early infantile,9,300088
chr12:33009217-33141070	0.132	PKP2	602861	(confirmed) Arrhythmogenic right ventricular dysplasia 9,609040
chr4:101240849-101364903	0.124	EMCN		
chr4:121637208-121750729	0.114	PRDM5	614161	(provisional) Brittle cornea syndrome 2,614170
chrX:108650264-108761585	0.111	GUCY2F		
chr4:118597223-118699888	0.103			
chr2:166038548-166130008	0.091			
chr2:166038548-166130008	0.091	SCN2A	182390	(confirmed) Seizures,benign familial infantile,3,607745|Epileptic encephalopathy,early infantile,11,613721
chr12:61909160-61991236	0.082			
chr2:154950271-155032548	0.082	GALNT13		
chrX:96668047-96746709	0.079	DIAPH2	300108	(confirmed) Premature ovarian failure 2A,300511
chr16:47380517-47449122	0.069	ITFG1		
chr12:59006002-59053347	0.047			
chr12:60631985-60652609	0.021			
chr14:65774207-65790248	0.016			
chr12:54768447-54775179	0.007	ZNF385A		
chr4:54136362-54140472	0.004	SCFD2		
chrX:48680521-48682029	0.002	HDAC6	300272	(confirmed) Chondrodysplasia with platyspondyly,distinctive brachydactyly,hydrocephaly,and microphthalmia,300863
chrX:90450654-90450811	0.000			
